Sharon See

535 total citations
21 papers, 355 citations indexed

About

Sharon See is a scholar working on Pharmacology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sharon See has authored 21 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Neurology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sharon See's work include Drug-Induced Adverse Reactions (3 papers), Urticaria and Related Conditions (3 papers) and Neurological and metabolic disorders (3 papers). Sharon See is often cited by papers focused on Drug-Induced Adverse Reactions (3 papers), Urticaria and Related Conditions (3 papers) and Neurological and metabolic disorders (3 papers). Sharon See collaborates with scholars based in United States. Sharon See's co-authors include Regina Ginzburg, John M. Conry, Sum Lam, Margaret Jordan Halter, Lisa Young, Wendy Barr, Sarah Nosal, Róbert Schiller, Susan Rubin and JAMES G. MUMFORD and has published in prestigious journals such as The Annals of Family Medicine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Sharon See

19 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon See United States	10	79	57	52	35	35	21	355
Toni L. Ripley United States	11	47 0.6×	79 1.4×	33 0.6×	106 3.0×	19 0.5×	29	493
J. Chris Bradberry United States	12	25 0.3×	29 0.5×	49 0.9×	79 2.3×	13 0.4×	20	382
Suzanne Novak United States	11	49 0.6×	48 0.8×	33 0.6×	163 4.7×	13 0.4×	17	415
Vincent Chan Australia	12	24 0.3×	62 1.1×	31 0.6×	45 1.3×	7 0.2×	34	382
Sophia M. Schild United States	6	32 0.4×	9 0.2×	34 0.7×	47 1.3×	48 1.4×	10	391
Matthew Zuckerman United States	10	57 0.7×	14 0.2×	56 1.1×	101 2.9×	22 0.6×	23	310
Ellen Weber United States	10	96 1.2×	24 0.4×	21 0.4×	53 1.5×	26 0.7×	27	370
Maisha Kelly Freeman United States	10	27 0.3×	37 0.6×	11 0.2×	46 1.3×	18 0.5×	29	343
Kathleen A. Packard United States	15	33 0.4×	20 0.4×	92 1.8×	65 1.9×	52 1.5×	49	673
Kaveh Eslami Iran	10	27 0.3×	20 0.4×	28 0.5×	29 0.8×	22 0.6×	36	297

Countries citing papers authored by Sharon See

Since Specialization

Citations

This map shows the geographic impact of Sharon See's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon See with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon See more than expected).

Fields of papers citing papers by Sharon See

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon See. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon See. The network helps show where Sharon See may publish in the future.

Co-authorship network of co-authors of Sharon See

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon See. A scholar is included among the top collaborators of Sharon See based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon See. Sharon See is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

See, Sharon, et al.. (2023). A Review of the Safety and Efficacy of Apixaban in Patients With Severe Renal Impairment. The Senior Care Pharmacist. 38(3). 86–94. 3 indexed citations

See, Sharon, et al.. (2021). Late-Onset Dystonia With Low-Dose Olanzapine in an Older Person: A Case Report. The Senior Care Pharmacist. 36(10). 493–500. 1 indexed citations

Lee, Mary, Joseph J. Saseen, Elizabeth J. Beckman, et al.. (2019). Expanding the pharmacist's scope of practice at the state level: Support for board certification within the credentialing process. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(6). 694–701. 3 indexed citations

See, Sharon & John M. Conry. (2014). Flip My Class! A faculty development demonstration of a flipped-classroom. Currents in Pharmacy Teaching and Learning. 6(4). 585–588. 58 indexed citations

Halter, Margaret Jordan, et al.. (2014). Transcultural Self-Efficacy Perceptions of Baccalaureate Nursing Students. Journal of Transcultural Nursing. 26(3). 327–335. 19 indexed citations

See, Sharon. (2013). Rediscovering Community--Reflections After Hurricane Sandy. The Annals of Family Medicine. 11(6). 571–573. 2 indexed citations

See, Sharon, et al.. (2011). Akathisia Induced by Gabapentin Withdrawal. Annals of Pharmacotherapy. 45(6). e31–e31. 22 indexed citations

See, Sharon, Sarah Nosal, Wendy Barr, & Róbert Schiller. (2009). Implementation of a Symptom-Triggered Benzodiazepine Protocol for Alcohol Withdrawal in Family Medicine Inpatients. Hospital Pharmacy. 44(10). 881–887. 6 indexed citations

See, Sharon & Regina Ginzburg. (2008). Skeletal Muscle Relaxants. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(2). 207–213. 59 indexed citations

10.

See, Sharon & Regina Ginzburg. (2008). Choosing a skeletal muscle relaxant.. PubMed. 78(3). 365–70. 63 indexed citations

11.

Lam, Sum & Sharon See. (2006). Exenatide. Cardiology in Review. 14(4). 205–211. 19 indexed citations

12.

See, Sharon & Susan Rubin. (2003). Tapering inhaled steroids effective for chronic asthma.. PubMed. 52(10). 748–51. 4 indexed citations

13.

See, Sharon, et al.. (2003). Digoxin increases mortality among women with congestive heart failure.. PubMed. 52(2). 106, 111–106, 111. 4 indexed citations

14.

See, Sharon. (2003). Desloratadine for allergic rhinitis.. PubMed. 68(10). 2015–6. 4 indexed citations

15.

See, Sharon. (2002). Carbamazepine effective for alcohol withdrawal.. PubMed. 51(9). 778–778. 5 indexed citations

16.

See, Sharon, et al.. (2002). Implementing and evaluating a pharmacy consult service within a family medicine residency program. American Journal of Health-System Pharmacy. 59(12). 1200–1204. 2 indexed citations

17.

See, Sharon. (2001). Angiotensin II receptor blockers for the treatment of hypertension. Expert Opinion on Pharmacotherapy. 2(11). 1795–1804. 21 indexed citations

18.

See, Sharon, et al.. (2001). Trimethoprim/Sulfamethoxazole—Induced Toxic Epidermal Necrolysis. Annals of Pharmacotherapy. 35(6). 694–697. 17 indexed citations

19.

See, Sharon, et al.. (2001). Trimethoprim/Sulfamethoxazole–Induced Toxic Epidermal Necrolysis. Annals of Pharmacotherapy. 35. 694–697.

20.

See, Sharon, et al.. (2000). Candesartan cilexetil: An angiotensin II-receptor blocker. American Journal of Health-System Pharmacy. 57(8). 739–746. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact